Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D/bioreactor model

Arthritis Research and Therapy

Volumn 15, Issue 4, 2013, Pages

  Peake, Nicholas ^a   Su, Nyan ^a   Ramachandran, Manoj ^b   Achan, Pramod ^b   Salter, Donald M ^c   Bader, Dan L ^a,d   Moyes, Amie J ^b   Hobbs, Adrian J ^b   Chowdhury, Tina T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; AGAROSE; C ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE 2 RECEPTOR; NATRIURETIC PEPTIDE 3 RECEPTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; P 19; PROSTAGLANDIN E2; RECEPTOR; UNCLASSIFIED DRUG; ATRIAL NATRIURETIC FACTOR RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C;

ADULT; AGED; ARTICLE; BIOMECHANICS; BIOREACTOR; BIOSYNTHESIS; CARTILAGE CELL; CATABOLISM; CELL PROTECTION; COMPRESSION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MECHANICAL STRESS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOLOGICAL MODEL; CARTILAGE; CELL CULTURE; FEMALE; FLUORESCENCE MICROSCOPY; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIOREACTORS; CARTILAGE; CELLS, CULTURED; FEMALE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MODELS, BIOLOGICAL; NATRIURETIC PEPTIDE, C-TYPE; OSTEOARTHRITIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION; STRESS, MECHANICAL;

EID: 84880353565     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4253     Document Type: Article

References (50)

1. Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR. Interaction of fibroblast growth factor and C-natriuretic peptide signalling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 2005, 118:5089-5100. 10.1242/jcs.02618, 16234329.
2. Waldman SD, Usmani Y, Tse MY, Pang SC. Differential effects of natriuretic peptide stimulation on tissue engineered cartilage. Tissue Eng Part A 2008, 14:441-448. 10.1089/tea.2007.0035, 18333796.
3. Ramachandran M, Achan P, Salter DM, Bader DL, Chowdhury TT. Biomechanical signals and the C-type natriuretic peptide counteract catabolic activities induced by IL-1β in chondrocyte/agarose constructs. Arthritis Res Ther 2011, 13:R145. 10.1186/ar3459, 3308073, 21914170.
4. Hagiwara H, Inoue A, Yamaguchi A, Yokose S, Furuya M, Tanaka S, Hirose S. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am J Physiol 1996, 270:C1311-C1308.
5. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 2001, 98:4016-4021. 10.1073/pnas.071389098, 31171, 11259675.
6. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, Hofmann F. Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol 1999, 135:105-149. 10.1007/BFb0033671, 9932482.
7. Komatsu Y, Chusho H, Tamura N, Yasoda A, Miyzawa T, Suda M, Miura M, Ogawa Y, Nako K. Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J Bone Miner Metab 2002, 20:331-336. 10.1007/s007740200048, 12434160.
8. Yasoda A, Ogawa Y, Suda M, Tamura N, Mori K, Sakuma Y, Chusho H, Shiota K, Tanaka K, Nakao K. Natriuretic peptide regulation of endochondral ossification: evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem 1998, 273:11695-11700. 10.1074/jbc.273.19.11695, 9565590.
9. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K. Overexpression of CNP in chondrocytes rescues achondroplasia through an MAPK-dependent pathway. Nat Med 2004, 10:80-86. 10.1038/nm971, 14702637.
10. Schulz S. C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 2005, 26:1024-1034. 10.1016/j.peptides.2004.08.027, 15911070.
11. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 2004, 99:76-82. 10.1007/s00395-004-0460-0, 14963665.
12. Matsukawa N, Grzesik WJ, Pandey KN, Pang S, Yamauchi M, Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. PNAS 1999, 96:7403-7408. 10.1073/pnas.96.13.7403, 22098, 10377427.
13. Kaneki H, Kurokawa M, ide H. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. J Cell Biochem 2008, 103:753-764. 10.1002/jcb.21448, 17562543.
14. Khambata RS, Panayiotou CM, Hobbs AJ. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br J Pharmacol 2011, 164:584-597. 10.1111/j.1476-5381.2011.01400.x, 3178781,3178781, 21457229.
15. Lee DA, Bader DL. Compressive strains at physiological frequencies influence the metabolism of chondrocytes seeded in agarose. J Orthop Res 1997, 15:181-188. 10.1002/jor.1100150205, 9167619.
16. Lee DA, Knight MM. Mechanical loading of chondrocytes embedded in 3D constructs: in vitro methods for assessment of morphological and metabolic response to compressive strain. Methods Mol Med 2004, 100:307-324.
17. Zhao Y, Brandish PE, DiValentin M, Schelvis JP, Babcock GT, Marletta MA. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 2000, 39:10848-10854. 10.1021/bi9929296, 10978171.
18. Deschenes J, Dupere C, McNicoll N, L'Hereux N, Auger F, Fournier A, De Lean A. Development of a selective peptide antagonist for the human natriuretic peptide receptor-B. Peptides 2005, 26:517-524. 10.1016/j.peptides.2004.10.017, 15652659.
19. Chowdhury TT, Bader DL, Shelton JC, Lee DA. Temporal regulation of chondrocyte metabolism in agarose constructs subjected to dynamic compression. Arch Biochem Biophys 2003, 417:105-111. 10.1016/S0003-9861(03)00340-0, 12921786.
20. Lee DA, Brand J, Salter D, Akanji OO, Chowdhury TT. Quantification of mRNA using real-time PCR and Western blot analysis of MAPK events in chondrocyte/agarose constructs. Methods Mol Biol 2011, 695:77-97. 10.1007/978-1-60761-984-0_6, 21042967.
21. Chowdhury TT, Arghandawi S, Brand J, Akanji OO, Salter DM, Bader DL, Lee DA. Dynamic compression counteracts IL-1β induced inducible nitric oxide synthase and cyclo-oxygenase-2 expression in chondrocyte/agarose constructs. Arthritis Res Ther 2010, 10:R35.
22. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real time PCR. Nucleic acids research 2002, 30:e3. 10.1093/nar/30.2.e3, 99842, 11788729.
23. Chowdhury TT, Bader DL, Lee DA. Dynamic compression inhibits the synthesis of nitric oxide and PGE2 by IL-1β stimulated chondrocytes cultured in agarose constructs. Biochem Biophys Res Commun 2001, 285:1168-1174. 10.1006/bbrc.2001.5311, 11478777.
24. Yamashita Y, Takeshige K, Inoue A, Hirose S, Takamori A, Hagiwara H. Concentration of mRNA for the natriuretic peptide receptor-C in hypertrophic chondrocytes of the fetal mouse tibia. J Biochem 2000, 127:177-179. 10.1093/oxfordjournals.jbchem.a022591, 10731681.
25. Hashim S, Li Y, Anand-Srivastava MB. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways. Am J Physiol Heart Circ Physiol 2006, 291:H3144-H3153. 10.1152/ajpheart.00327.2006, 16920814.
26. Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP. Chondrocytes respond to adenoside via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthritis Cartilage 2002, 10:34-43. 10.1053/joca.2001.0479, 11795981.
27. Karsdal MA, Sondergaard BC, Arnold M, Christiansen C. Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis?. Ann NY Acad Sci 2007, 1117:181-195. 10.1196/annals.1402.041, 18056043.
28. Boyan BD, Sylvia VL, Dean DD, Del Toro F, Schwartz Z. Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit Rev Oral Biol Med 2002, 13:143-154. 10.1177/154411130201300205, 12097357.
29. D'Andrea P, Calabrese A, Capozzi I, Grandolfo M, Tonon R, Vittur F. Intercellular Ca2+ waves in mechanically stimulated articular chondrocytes. Biorheology 2000, 37:75-83.
30. Roberts SR, Knight MM, Lee DA, Bader DL. Mechanical compression influences intracellular Ca2+ signaling in chondrocytes seeded in agarose constructs. J Appl Physiol 2001, 90:1385-1391.
31. Geng Y, Zhou L, Thompson WJ, Lotz M. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes. J Biol Chem 1998, 273:27484-27491. 10.1074/jbc.273.42.27484, 9765278.
32. Mancini L, Moradi-Bidhendi N, Becherini L, Martineti V, MacIntyre I. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependant. Biochem Biophys Res Commun 2000, 274:477-481. 10.1006/bbrc.2000.3164, 10913363.
33. Mercapide J, Santiago E, Alberdi E, Martinez-Irujo JJ. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Biochem Pharmacol 1999, 58:1675-1683. 10.1016/S0006-2952(99)00252-X, 10535760.
34. Pedraza CE, Baltrons MA, Garcia A. Interleukin-1beta stimulates cyclic GMP efflux in brain astrocytes. FEBS Lett 2001, 507:303-306. 10.1016/S0014-5793(01)03003-4, 11696360.
35. Sager G. Cyclic GMP transporters. Neurochem Int 2004, 45:865-873. 10.1016/j.neuint.2004.03.017, 15312981.
36. Schulz T, Schumacher U, Prehm P. Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem 2007, 282:20999-21004. 10.1074/jbc.M700915200, 17540771.
37. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996, 55:424-431. 10.1136/ard.55.7.424, 1010204, 8774159.
38. Dieters B, Prehm P. Inhibition of hyaluronan export reduces collagen degradation in interleukin-1 treated cartilage. Arthritis Res Ther 2008, 10:R8. 10.1186/ar2357, 2374471, 18205921.
39. Lewko B, Bryl E, Witkowski JM, Matawiec E, Golos M, Endlich N, Hahnel B, Koksch C, Angielski S, Kriz W, Stepinski J. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney Int 2004, 66:1001-1008. 10.1111/j.1523-1755.2004.00848.x, 15327393.
40. Deschner J, Hofman CR, Piesco NP, Agarwal S. Signal transduction by mechanical strain in chondrocytes. Curr Opin Clin Nutr Metab Care 2003, 6:289-293.
41. Madhavan S, Anghelina M, Rath-Deschner B, Deschner J, Piesco N, Agarwal S. Biomechanical signals exert sustained attenuation of proinflammatory gene induction in articular chondrocytes. Osteoarthrit Cart 2006, 14:1023-1032.
42. De Croos JN, Dhaliwal SS, Grynpas MD, Pilliar RM, Kandel RA. Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation. Matrix Biol 2006, 25:323-331. 10.1016/j.matbio.2006.03.005, 16697175.
43. Akanji OO, Sakthithasan P, Salter DM, Chowdhury TT. Dynamic compression alters NFkappaB activation and IkappaB-alpha expression in IL-1beta-stimulated chondrocyte/agarose constructs. Inflamm Res 2010, 59:41-52. 10.1007/s00011-009-0068-9, 19669392.
44. Millward-Sadler SJ, Wright MO, Lee H, Nishida K, Caldwell H, Nuki G, Salter DM. Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes. J Cell Biol 1999, 145:183-189. 10.1083/jcb.145.1.183, 2148217, 10189377.
45. Millward-Sadler SJ, Wright MO, Flatman PW, Salter DM. ATP in the mechanotransduction pathway of normal human chondrocytes. Biorheology 2004, 41:567-575.
46. Chowdhury TT, Salter DM, Bader DL, Lee DA. Integrin-mediated mechanotransduction processes in TGFbeta-stimulated monolayer-expanded chondrocytes. Biochem Biophys Res Commun 2004, 318:873-881. 10.1016/j.bbrc.2004.04.107, 15147953.
47. Rangaswami H, Marathe N, Zhuang S, Chen Y, Yeh JC, Frangos JA, Boss GR, Pilz RB. Type II cGMP-dependant protein kinase mediates osteoblast mechanotransduction. J Biol Chem 2009, 284:14796-14808. 10.1074/jbc.M806486200, 2685661, 19282289.
48. Fitzgerald J, Hughes-Fulford M. Mechanically induced c-fos expression is mediated by cAMP in MC3T3-E1 osteoblasts. FASEB J 1999, 13:553-557.
49. Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Doi K, Inoue M, Masatsugu K, Korenaga R, Ando J, Nakao K. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997, 29:1296-12302. 10.1161/01.HYP.29.6.1296, 9180632.
50. Suga S, itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993, 133:3038-3041. 10.1210/en.133.6.3038, 8243333.